Aminopyrine

CHEMBL288470 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
231.3 g/mol
LogP
1.0
Phase
4

An analgesic and antipyretic drug that reduces pain and fever by inhibiting prostaglandin synthesis, once widely used but now largely abandoned because of its ability to cause agranulocytosis, a dangerous depletion of white blood cells. It has been replaced by safer alternatives like paracetamol and ibuprofen.

Khối lượng phân tử

231,2900 g/mol

LogP

1,00

TPSA

26,80 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C

InChI

InChI=1S/C13H17N3O/c1-10-12(14(2)3)13(17)16(15(10)4)11-8-6-5-7-9-11/h5-9H,1-4H3

Molecular Formula

C13H17N3O

HBD / HBA

- / 3

Liên kết có thể quay

2

Nguyên tử nặng

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

An analgesic and antipyretic drug that reduces pain and fever by inhibiting prostaglandin synthesis, once widely used but now largely abandoned because of its ability to cause agranulocytosis, a dangerous depletion of white blood cells. It has been replaced by safer alternatives like paracetamol and ibuprofen.

Yes, Aminopyrine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL288470. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6009. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.